Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: A role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicity

FEBS Letters

Volumn 538, Issue 1-3, 2003, Pages 145-148

  Hashimoto, Ryota ^a   Fujimaki, Koichiro ^a   Jeong, Mi Ra ^a   Christ, Lori ^a   Chuang, De Maw ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bipolar disorder; Cerebral cortical neuron; Lithium; Src kinase; Tyrosine phosphorylation

Indexed keywords

GLUTAMIC ACID; IFENPRODIL; LITHIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN TYROSINE KINASE; TYROSINE;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL ASSAY; CONTROLLED STUDY; DENSITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME INHIBITION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TIME;

EID: 0037434847     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00167-4     Document Type: Article

References (22)

1. Brown M.T., Cooper J.A. Biochim. Biophys. Acta. 1287:1996;121-149.
2. Ali D.W., Salter M.W. Curr. Opin. Neurobiol. 11:2001;336-342.
3. Yu X.M., Askalan R., Keil G.J. II, Salter M.W. Science. 275:1997;674-678.
4. Salter M.W. Biochem. Pharmacol. 56:1998;789-798.
5. Nakazawa T., Komai S., Tezuka T., Hisatsune C., Umemori H., Semba K., Mishima M., Manabe T., Yamamoto T. J. Biol. Chem. 276:2001;693-699.
6. Cheung H.H., Gurd J.W. J. Neurochem. 78:2001;524-534.
7. Takasu M.A., Dalva M.B., Zigmond R.E., Greenberg M.E. Science. 295:2002;491-495.
8. Chuang D.-M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., Leeds P. Bipolar Disord. 4:2002;129-136.
9. Manji H.K., Moore G.J., Chen G. Biol. Psychiatry. 46:1999;929-940.
10. Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D.-M. J. Neurochem. 80:2002;589-597.
11. Nonaka S., Hough C.J., Chuang D.-M. Proc. Natl. Acad. Sci. USA. 95:1998;2642-2647.
12. Hashimoto R., Nakamura Y., Komai S., Kashiwagi Y., Tamura K., Goto T., Aimoto S., Kaibuchi K., Shiosaka S., Takeda M. J. Neurochem. 75:2000;373-382.
13. Kashiwagi Y., Nakamura Y., Miyamae Y., Hashimoto R., Takeda M. Neurosci. Lett. 252:1998;5-8.
14. Hashimoto R., Takei N., Shimazu K., Christ L., Lu B., Chuang D.-M. Neuropharmacology. 43:2002;1173-1179.
15. Hashimoto R., Nakamura Y., Imamura K., Nakadate K., Kashiwagi Y., Matsumoto N., Takeda M. Eur. J. Neurosci. 14:2001;1237-1245.
16. Kornau H.-C., Schenker L.T., Kennedy M.B., Seeburg P.H. Science. 269:1995;1737-1740.
17. Kim J.H., Liao D., Lau L.-F., Huganir R.L. Neuron. 20:1998;683-691.
18. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., Courtneidge S.A. Mol. Cell. Biol. 20:2000;9018-9027.
19. Williams K., Russell S.L., Shen Y.M., Molinoff P.B. Neuron. 10:1993;267-278.
20. Zhen X., Torres C., Friedman E. Psychopharmacology. 162:2002;379-384.
21. Chenard B.L., Menniti F.S. Curr. Pharm. Des. 5:1999;381-404.
22. Steece-Collier K., Chambers L.K., Jaw-Tsai S.S., Menniti F.S., Greenamyre J.T. Exp. Neurol. 163:2000;239-243.